Subthalamic activity during diphasic dyskinesias in Parkinson's disease

Movement Disorders

Volumn 27, Issue 9, 2012, Pages 1178-1181

  Alegre, Manuel ^a,b   López Azcárate, Jon ^a   Alonso Frech, Fernando ^b   Rodríguez Oroz, Maria C ^a,b   Valencia, Miguel ^a   Guridi, Jorge ^b   Artieda, Julio ^a,b   Obeso, José A ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Diphasic dyskinesias; Local field potentials; Subthalamic nucleus

Indexed keywords

DOPA DECARBOXYLASE INHIBITOR; LEVODOPA;

ADULT; AGED; ARTICLE; BETA RHYTHM; BRAIN DEPTH STIMULATION; DIPHASIC DYSKINESIA; DYSKINESIA; FEMALE; FOURIER TRANSFORMATION; GAMMA RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; OSCILLATORY POTENTIAL; PARKINSON DISEASE; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; THETA RHYTHM;

AGED; ANTIPARKINSON AGENTS; APOMORPHINE; COHORT STUDIES; DEEP BRAIN STIMULATION; DISEASE PROGRESSION; DYSKINESIAS; ELECTRODES, IMPLANTED; FEMALE; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; THETA RHYTHM;

EID: 84864770710     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25090     Document Type: Article

References (25)

1. Muenter MD, Sharpless NS, Tyce GM, Darley FL. Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease. Mayo Clin Proc. 1977; 52: 163-174.
2. Lhermitte F, Agid Y, Signoret JL, Studler JM. Les dyskinesies de "debut et fin de dose" provoquees par la L-DOPA. Rev Neurol (Paris). 1977; 133: 297-308.
3. Luquin MR, Scipioni O, Vaamonde J, Gershanik O, Obeso JA. Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. Mov Disord. 1992; 7: 117-124.
4. Fahn S. The spectrum of levodopa-induced dyskinesias. Ann Neurol. 2000; 47: S2-S9.
5. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord. 2005; 20( Suppl 11):S11-6.: S11-S16.
6. Marconi R, Lefebvre-Caparros D, Bonnet AM, Vidailhet M, Dubois B, Agid Y. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Mov Disord. 1994; 9: 2-12.
7. Obeso JA, Grandas F, Vaamonde J, et al. Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology. 1989; 39: 11-19.
8. Lhermitte F, Agid Y, Signoret JL. Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa. Arch Neurol. 1978; 35: 261-263.
9. Nutt JG. Clinical pharmacology of levodopa-induced dyskinesia. Ann Neurol. 2000; 47: S160-S164.
10. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, Olanow CW. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Ann Neurol. 2000; 47: S22-S32.
11. Bravi D, Mouradian MM, Roberts JW, Davis TL, Chase TN. End-of-dose dystonia in Parkinson's disease. Neurology. 1993; 43: 2130-2131.
12. Priori A, Foffani G, Pesenti A, et al. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease. Exp Neurol. 2004; 189: 369-379.
13. Brown P, Oliviero A, Mazzone P, Insola A, Tonali P, Di L, V. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci. 2001; 21: 1033-1038.
14. Alonso-Frech F, Zamarbide I, Alegre M, et al. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain. 2006; 129: 1748-1757.
15. Lopez-Azcarate J, Tainta M, Rodriguez-Oroz MC, et al. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease. J Neurosci. 2010; 30: 6667-6677.
16. Foffani G, Priori A, Egidi M, et al. 300-Hz subthalamic oscillations in Parkinson's disease. Brain. 2003; 126: 2153-2163.
17. Rodriguez-Oroz MC, Lopez-Azcarate J, Garcia-Garcia D, et al. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain. 2011; 134: 36-49.
18. Alegre M, Alonso-Frech F, Rodriguez-Oroz MC, et al. Movement-related changes in oscillatory activity in the human subthalamic nucleus: ipsilateral vs. contralateral movements. Eur J Neurosci. 2005; 22: 2315-2324.
19. Brown P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord. 2003; 18: 357-363.
20. Gatev P, Darbin O, Wichmann T. Oscillations in the basal ganglia under normal conditions and in movement disorders. Mov Disord. 2006; 21: 1566-1577.
21. Kuhn AA, Tsui A, Aziz T, et al. Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp Neurol. 2009; 215: 380-387.
22. Kuhn AA, Kempf F, Brucke C, et al. High-Frequency stimulation of the subthalamic nucleus suppresses oscillatory {beta} activity in patients with Parkinson's disease in parallel with improvement in motor performance. J Neurosci. 2008; 28: 6165-6173.
23. Brown P, Kupsch A, Magill PJ, Sharott A, Harnack D, Meissner W. Oscillatory local field potentials recorded from the subthalamic nucleus of the alert rat. Exp Neurol. 2002; 177: 581-585.
24. Tolosa ES, Martin WE, Cohen HP, Jacobson RL. Patterns of clinical response and plasma dopa levels in Parkinson's disease. Neurology. 1975; 25: 177-183.
25. Rodriguez-Oroz MC, Rodriguez M, Guridi J, et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain. 2001; 124: 1777-1790.